CEVR analyzes the benefits, risks, and costs of strategies to improve health and health care.

About Us
Data

News & Events

Recent Publications

Analytic considerations in applying a general economic evaluation reference case to gene therapy

Value in Health

Drummond MF, Neumann PJ, Sullivan SD, Fricke FU, Tunis S, Dabbous O, Toumi M. Analytic considerations in applying a general economic evaluation reference case to gene therapy. Value in Health 2019 (in press).

Taking stock of cost-effectiveness analysis of healthcare in China

BMJ Global Health

Butt T, Liu GG, Kim DD, Neumann PJ. Taking stock of cost-effectiveness analysis of healthcare in China. BMJ Global Health 2019;4(3):1–9.

Publication of decision model source code: Attitudes of health economics authors

PharmacoEconomics

Emerson J, Bacon R, Kent A, Neumann PJ, Cohen JT. Publication of decision model source code: Attitudes of health economics authors. PharmacoEconomics 2019;:1–2.

Adherence to the iDSI reference case among published cost-per-DALY averted studies

PLoS ONE

Emerson J, Panzer A, Cohen JT, Chalkidou K, Teerawattananon Y, Sculpher M, Wilkinson T, Walker D, Neumann PJ, Kim DD. (2019) Adherence to the iDSI reference case among published cost-per-DALY averted studies. PLoS ONE 14(5): e0205633.

Assessment of parents’ preferences for incentives to promote engagement in family-based childhood obesity treatment

JAMA Open Network

Wright DR, Saelens BE, Fontes A, Lavelle TA. Assessment of Parents’ Preferences for Incentives to Promote Engagement in Family-Based Childhood Obesity Treatment. JAMA Network Open 2019;2(3).

Family and caregiver spillover effects in cost‑utility analyses of Alzheimer’s disease interventions

PharmacoEconomics

Lin PJ, D'Cruz B, Leech AA, Neumann PJ, Aigbogun MS, Oberdhan D, Lavelle TA. Family and caregiver spillover effects in cost‑utility analyses of Alzheimer’s disease interventions. PharmacoEconomics 2019;37(3):1–12.

Parent preferences for health outcomes associated with autism spectrum disorder

PharmacoEconomics

Lavelle TA, Weinstein MC, Newhouse JP, Munir K, Kuhlthau KA, Prosser LA. Parent preferences for health outcomes associated with autism spectrum disorders. PharmacoEconomics 2019;37(4):541–51.

Exploring the prevalence and construct validity of high-impact chronic pain across chronic low-back pain study samples

The Spine Journal

Herman PM, Broten N, Lavelle TA, Sorbero ME, Coulter ID. Exploring the prevalence and construct validity of high-impact chronic pain across chronic low-back pain study samples. The Spine Journal 2019 (in press).

Healthcare costs and opioid use associated with high-impact chronic spinal pain in the United States

The Spine Journal

Herman PM, Broten N, Lavelle TA, Sorbero ME, Coulter ID. Healthcare costs and opioid use associated with high-impact chronic spinal pain in the United States. Spine 2019 (in press).

Leveraging cumulative network meta-analysis and value of information analysis to understand the evolving value of medical research

Medical Decision Making

Kim DD, Trikalinos TA, Wong JB. Leveraging cumulative network meta-analysis and value of information analysis to understand the evolving value of medical research. Medical Decision Making 2019;39(2):119–29.

Targeted incentive programs for lung cancer screening can improve population health and economic efficiency

Health Affairs

Kim DD, Cohen JT, Wong JB, Mohit B, Fendrick AM, Kent DM, Neumann PJ. Targeted incentive programs for lung cancer screening can improve population health and economic efficiency. Health Affairs 2019;38(1):60–7.

Discrepancies between FDA-required labeling and evidence that payers cite in drug coverage policies

Journal of Managed Care & Specialty Pharmacy

Chambers JD, Pope EF, Wilkinson CL, Neumann PJ. Discrepancies between FDA-required labeling and evidence that payers cite in drug coverage policies. Journal of Managed Care & Specialty Pharmacy 2018;24(12):1240–6.

Family spillover effects in pediatric cost-utility analyses

Applied Health Economics and Health Policy

Lavelle TA, D’Cruz BN, Mohit B, Ungar WJ, Prosser LA, Tsiplova K, Monserrat VL, Lin PJ. Family spillover effects in pediatric cost-utility analyses. Applied Health Economics and Health Policy 2018;

Future directions for cost-effectiveness analyses in health and medicine

Medical Decision Making

Neumann PJ, Kim DD, Trikalinos TA, Sculpher MJ, Salomon JA, Prosser LA, Owens DK, Meltzer DO, Kuntz KM, Krahn M, Feeny D, Basu A, Russell LB, Siegel JE, Ganiats TG, Sanders GD. Future Directions for Cost-effectiveness Analyses in Health and Medicine. Medical Decision Making 2018;38:767-77.

Comorbidity type and health care costs in type 2 diabetes: A retrospective claims database analysis

Diabetes Therapy

Lin P-J, Pope E, Zhou FL. Comorbidity type and health care costs in type 2 diabetes: A retrospective claims database analysis. Diabetes Therapy 2018;

The CEVR Team

Our team of experienced, dedicated researchers is led by health economists Peter Neumann and Josh Cohen. Together we produce cutting-edge health care cost-effectiveness research.

Meet the CEVR Team

Our Databases

Our comprehensive databases provide the information individuals and organizations need to analyze the benefits, risks, and costs of strategies to improve health and health care.